CORRESP Filing
Propanc Biopharma, Inc.
Date: July 29, 2025 · CIK: 0001517681 · Accession: 0001641172-25-021452
AI Filing Summary & Sentiment
Reasoning
Letter
Re: Propanc Biopharma, Inc. Registration Statement on Form S-1, as amended File No. 333- 282886
July 29, 2025
VIA EDGAR CORRESPONDENCE
U.S. Securities and Exchange Commission
Division of Corporation Finance
F Street, N.E.
Washington, D.C. 20549
REQUEST FOR WITHDRAWAL OF ACCELERATION OF EFFECTIVENESS
Ladies and Gentlemen:
Reference is made to our letter, dated July 24, 2025 in which we requested acceleration of the effective date of the above referenced Registration Statement to 4:30 p.m., Eastern Time, on July 28, 2025. We are no longer requesting that such Registration Statement be declared effective at such time, and we hereby formally, and with immediate effect, withdraw our request for acceleration of the effective date.
Very truly yours,
D. Boral capital llc
Show Raw Text
CORRESP 1 filename1.htm July 29, 2025 VIA EDGAR CORRESPONDENCE U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: Propanc Biopharma, Inc. Registration Statement on Form S-1, as amended File No. 333- 282886 REQUEST FOR WITHDRAWAL OF ACCELERATION OF EFFECTIVENESS Ladies and Gentlemen: Reference is made to our letter, dated July 24, 2025 in which we requested acceleration of the effective date of the above referenced Registration Statement to 4:30 p.m., Eastern Time, on July 28, 2025. We are no longer requesting that such Registration Statement be declared effective at such time, and we hereby formally, and with immediate effect, withdraw our request for acceleration of the effective date. Very truly yours, D. Boral capital llc By: /s/ Philip Wiederlight Name: Philip Wiederlight Title: Chief Operating Officer